A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/40 (2006.01) A61K 9/00 (2006.01) A61K 9/20 (2006.01) A61K 31/407 (2006.01)
Patent
CA 2182981
The invention relates to a sublingual or buccal pharmaceutical composition comprising trans-5-chloro-2-methyl-2,3,3a, 12b-tetrahydro- 1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole or a pharmaceutically acceptable salt thereof, and, pharmaceutically acceptable auxiliaries suitable for use in sublingual or buccal compositions, and the use thereof for the manufacture of a sublingual or buccal pharmaceutical composition for the treatment of mental disorders, such as psychosis and schizophrenia.
L'invention se rapporte à une composition pharmaceutique sublinguale ou buccale comprenant le trans-5-chloro-2-méthyl-2,3,3a,12b-tétrahydro-1H-dibenz[2,3:6,7]oxépino[4,5-c]pyrrole ou un sel de celui-ci pharmacologiquement acceptable, ainsi qu'aux excipients pharmacologiquement acceptables appropriés aux compositions sublinguales ou buccales; l'invention se rapporte également à l'utilisation de ce composé pour la fabrication d'une composition pharmaceutique sublinguale ou buccale destinée au traitement de troubles mentaux, notamment la psychose et la schizophrénie.
Delbressine Leonardus Petrus Carla
Wieringa Johannes Hubertus
Akzo Nobel N.v.
Fetherstonhaugh & Co.
N.v. Organon
LandOfFree
Sublingual or buccal pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sublingual or buccal pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sublingual or buccal pharmaceutical composition will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1699217